MedCity News

A human hand interacts with an artificial intelligence robotic hand with medical icons and a digital interface on dark background, illustrating healthcare technology AI trust

AI-Driven Precision Care is the Fix for Our Health System’s Failures

The Quiet Battle for the Front Door of Healthcare

This is not a debate about care models or physician preferences. It is a contest over who will control the referral pathways and the revenue streams that originate at the front door of healthcare.

By Dana Y. Lujan

Payers

Insurers have Cut Prior Auth by 11% Following Commitments

Health insurers have reduced prior authorizations by 11% and are continuing reforms to streamline and speed up approvals, according to an announcement from AHIP and Blue Cross Blue Shield Association.

By Marissa Plescia

Sponsored Post

How to Use Real-World Data to Improve Drug Development, Starting with the Patient Journey

A new eBook explores how using real world data from patients can help drug developers improve outcomes for non-small cell lung cancer and other patient populations.

By Stephanie Baum

Latest Video

Latest News

BioPharma, Pharma

Trial Failure in the Skin Does Not Dent Insmed Drug’s Potential in the Lungs

Insmed drug Brinsupri failed to beat a placebo in a mid-stage clinical trial testing the daily pill as a treatment for hidradenitis suppurativa, a chronic inflammatory skin disorder. Brinsupri is still projected to become a blockbuster seller in non-cystic fibrosis bronchiectasis, where it is the first approved therapy for this chronic lung condition.

By Frank Vinluan

Providers, Hospitals, Payers, Legal

Judge gavel and bundled cash on white background representing financial crime, corruption, and legal consequences

Jefferson Health Sues Aetna As Providers’ Frustration with MA Grows

Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly reduces reimbursements for legitimate inpatient stays. The case highlights a broader clash between providers and Medicare Advantage plans over “downcoding” short hospital stays and controlling costs.

By Katie Adams

Sponsored Post

Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]

How to turn analytics into actual policy outcomes.

By Sellers Dorsey and MedCity News

MedCity Influencers

Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies

Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as “FixHealthcareGPT,” and investing in the wrong technology for the future isn’t going to do anything to improve patient outcomes today.

By Denis Whelan

MedCity Influencers

It’s Time to Put Guardrails on GLP-1 Compounding

Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products.

By Nancy Glick

Sponsored Post

The Hidden Administrative Tasks Draining Small Practices

Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Consumer / Employer, Providers

Spotlight Circle Light Focus on the Coin Slot of a Pink Colored Piggy Bank on Pink Background Directly Above View.

Do Healthcare CEOs Agree on Whether VBC and MA Actually Save Money?

Healthcare leaders can’t tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven’t delivered measurable savings and point to direct contracting as a more transparent way to control spending.

By Katie Adams

BioPharma, Pharma

Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis

Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas.

By Frank Vinluan

Sponsored Post

The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]

MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.

By Clever Care Health Plan and MedCity News

MedCity Influencers

Stop Waiting to Be Asked: What Operators Really Need From Their Revenue Cycle Partners

When revenue cycle partners wait to be asked, or rely on “tell us what you need” as a default, they miss critical opportunities to deliver meaningful performance, support their client organizations, and ultimately serve patients better. In today’s healthcare environment, partnership requires anticipation, not reaction.

By Brianne Morrill

MedCity Influencers

How Tech-Enabled Independent Pharmacies Can Address America’s Medication Adherence Crisis

Today’s technology has the potential to empower independent pharmacies to offer adherence support at a greater scale — and healthcare engagements that overlook this touchpoint miss out.

By Andy Maurer

Opinion

Women’s Health Is Central to the Future of Digital Health

Innovation in women’s health technology is about improving input data, refining performance criteria and ensuring design assumptions align with biological reality and real-world usage. When those fundamentals are in place, products are more accurate, more trustworthy and more likely to be adopted by clinicians and consumers alike.

By Kinsey Fabrizio

Health Tech, Startups

Trading digital board showing the data on rising stock market.

Digital Health Startups Raised $4B in Q1: How Cash Is Flowing Amid Uncertainty

Digital health funding rebounded in the first quarter of 2026, reaching $4 billion across 110 deals, according to data from Rock Health. The surge was fueled mainly by megadeals, reflecting a market where investors are placing larger bets on fewer startups.

By Katie Adams

Artificial Intelligence, Providers

CEO Building AI’s “Health Universe” Utterly Unperturbed By Rivals

"We spend a lot of time focused on building the experiences that we think are the future of healthcare, and we don't spend a heck of a lot of time worrying about what other people are doing," declares Dan Caron, founder and CEO of Health Universe. Here's a Q&A with the leader of the Kleiner Perkins-backed company.

By Arundhati Parmar

Health Tech

TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost

Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo.

By Marissa Plescia

BioPharma, Pharma

Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug

Soleno Therapeutics brings Neurocrine Biosciences Vykat XR, a drug commercialized for treating the rare genetic disease Prader-Willi syndrome. This blockbuster prospect complements Crenessity, a Neurocrine drug approved for treating a rare endocrine disorder called congenital adrenal hyperplasia.

By Frank Vinluan

MedCity Influencers

From Data Ownership to Learning Velocity in Direct-to-Consumer Healthcare

As commercialization increasingly reflects direct engagement dynamics, differentiation depends less on the volume of data controlled and more on the speed at which systems incorporate feedback.

By Osama Usmani